mln1117
Showing 1 - 3 of 3
Clear-cell Metastatic Renal Cell Carcinoma Trial in Worldwide (Everolimus, MLN0128, MLN1117)
Completed
- Clear-cell Metastatic Renal Cell Carcinoma
- Everolimus
- +2 more
-
Los Angeles, California
- +35 more
Nov 18, 2021
Endometrial Tumors Trial in Worldwide (Paclitaxel, Sapanisertib, MLN1117)
Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma Trial in Spain, United States (MLN1117, TAK-659, Alisertib)
Terminated
- Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma
- MLN1117
- +4 more
-
Lake Success, New York
- +5 more
Aug 19, 2019